Apexigen, Inc. Common Stock
APGN
APGN was delisted on the 22nd of August, 2023.
30 hedge funds and large institutions have $22.2M invested in Apexigen, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
1,100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
58% more funds holding
Funds holding: 19 → 30 (+11)
29% more capital invested
Capital invested by funds: $17.3M → $22.2M (+$4.96M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$991K |
| 2 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
+$915K |
| 3 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$742K |
| 4 |
KC
Kepos Capital
New York
|
+$454K |
| 5 |
CM
Crestline Management
Fort Worth,
Texas
|
+$406K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$17K |
| 2 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$5.82K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$991 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
UBS Group
Zurich,
Switzerland
| $26K | -$991 | -100 | -4% |
|
|
APC
27
Aspire Private Capital
Cornelius,
North Carolina
| $2K | +$1.98K | +200 | New |
|
|
CFA
28
Carroll Financial Associates
Charlotte,
North Carolina
| $2K | +$2.87K | +290 | New |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $1K | +$535 | +54 | New |
|
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$17K | -1,750 | Closed |
|
APGN Hedge Fund Activity: Q2 2021 in Review
30 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. Common Stock (APGN) for Q2 2021, worth a combined $22.2M — up 29% from $17.3M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new APGN positions and 1 closed out — a net gain of 11 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was CVI Holdings, opening a new position worth an estimated $991K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $17K sold.
- 30 institutional investors held Apexigen, Inc. Common Stock (APGN) as of Q2 2021, up from 19 in Q1 2021.
- Funds reported $22.2M of Apexigen, Inc. Common Stock stock for Q2 2021, up 29% quarter-over-quarter.
- 12 funds opened new Apexigen, Inc. Common Stock positions in Q2 2021 and 1 closed out, a net change of +11 holders.
- The largest Apexigen, Inc. Common Stock buyer in Q2 2021 was CVI Holdings, an estimated $991K added.
- The largest Apexigen, Inc. Common Stock seller in Q2 2021 was Royal Bank of Canada, an estimated $17K sold.
Based on aggregated 13F filings for Q2 2021.